Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Intra-arterial
100%
Minimally Invasive
100%
Locoregional Therapy
100%
Metastatic Melanoma
100%
Isolated Limb Infusion
100%
Percutaneous Hepatic Perfusion
100%
Melanoma
33%
Area Cover
33%
Phase II Trial
33%
High-dose Chemotherapy
33%
Percutaneous Procedure
33%
Liver
16%
Drug Delivery
16%
Therapeutic Potential
16%
Tumor Cells
16%
Target Organ
16%
Pharmacokinetics
16%
Clinical Response
16%
Systemic Chemotherapy
16%
Regional Chemotherapy
16%
Response Rate
16%
Treatment Alternatives
16%
Surgical Technique
16%
Expert Opinion
16%
Unresectable Liver Metastases
16%
Systemic Manifestations
16%
Difficult-to-treat
16%
In-transit Melanoma
16%
Systemic Exposure
16%
In-transit Metastasis
16%
Intra-arterial Therapy
16%
Clinical Situations
16%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Metastatic Melanoma
100%
High Dose Chemotherapy
66%
Chemotherapy Regimens
66%
Liver Metastasis
33%
Neoplasm
33%
Phase II Trials
33%
In-Transit Metastasis
33%
Pharmacokinetics
33%
Phase III Trials
33%
Medicine and Dentistry
Infusion
100%
Limb
100%
Metastatic Melanoma
100%
Melanoma
42%
High Dose Chemotherapy
28%
Liver Metastasis
14%
Pharmacokinetics
14%
Surgical Technique
14%
Tumor Cell
14%
Regional Perfusion
14%
Target Organ
14%
Intraarterial Drug Administration
14%
In-Transit Metastasis
14%
Phase II Trials
14%
Phase III Trials
14%
Chemotherapy
14%